Athanasios Thomaides, MD
Internal Medicine · Greenwood, INNPI 1134388853
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (37.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Medtronic at 29.5% of the total. Among internal medicine clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 360 payments — averaging $157.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$17K
- Atricure, Inc.$15K
- Medical Device Business Services, Inc.$13K
- Abbott$6K
- Biosense Webster, Inc.$2K
- Philips North America LLC$1K
- plus $3K from 27 others
Across 4 payments — averaging $2800.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$11K
What the payments were for
- Consulting fees$21,17537%
- Speaking & faculty fees$1,8753%
- Travel & lodging$19,86535%
- Food & beverage$13,90624%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 71 | $16,755 |
| Atricure, Inc. | 28 | $14,695 |
| Medical Device Business Services, Inc. | 11 | $12,750 |
| Abbott | 85 | $6,452 |
| Biosense Webster, Inc. | 38 | $1,617 |
| Philips North America LLC | 13 | $1,069 |
| Boston Scientific | 11 | $1,017 |
| Pfizer | 8 | $246 |
| Merck | 11 | $221 |
| Boehringer Ingelheim | 9 | $217 |
| Kestra Medical Technology Services, Inc. | 3 | $185 |
| Amgen | 4 | $181 |
| Johnson & Johnson | 9 | $173 |
| Novartis | 8 | $169 |
| Novo Nordisk | 6 | $137 |
| E.r. Squibb & Sons, L.L.C. | 8 | $136 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $122 |
| AstraZeneca | 4 | $80 |
| Lexicon Pharmaceuticals, Inc. | 3 | $75 |
| Cardiva Medical, Inc. | 3 | $73 |
| Bridgebio Pharma, Inc. | 3 | $71 |
| Bayer | 3 | $62 |
| Sanofi-aventis U.S. LLC | 2 | $60 |
| Angiodynamics, Inc. | 2 | $45 |
| Actelion Pharmaceuticals US, Inc. | 1 | $40 |
| Irhythm Technologies, Inc. | 2 | $38 |
| Esperion Therapeutics, Inc. | 1 | $28 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $22 |
| Biotronik Inc. | 1 | $21 |
| Elutia, Inc. | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$13,352
- SYNERGY ABLATION SYSTEM$9,696
- ISOLATOR SURGICAL ABLATION SYSTEM$6,839
- ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$2,858
- AVEIR$1,735
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$552
- (9124) LM Undivided$458
- COBALT DR MRI SURESCAN$437
- Assurity Pacemaker$428
- EVERA MRI XT DR SURESCAN$401
- ENSITE$263
- EMBLEM MRI S-ICD$206
- CLINICAL TRIAL PRODUCT$180
- CardioMEMS HF System$169
- JOT DX$164
- FARAWAVE$162
- Agilis NxT EP Introducer$158
- Emboshield NAV6 system$158
- (9520) IGT Devices Undivided$147
- ACCOLADE SR$146
How this compares
$56,821 in reported general payments places this provider in the 95th percentile of 1,747 internal medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 33 | $34,582 |
| XareltoRivaroxaban | 20 | $16,096 |
| Metoprolol Succinate | 34 | $388 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $246 | $34,58233 claims |
| Johnson & JohnsonXarelto | $173 | $16,09620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,747 internal medicine providers in Indiana.
Other internal medicine in Greenwood
- Abhinav SinghGreenwood$733K
- Steven SamuelsGreenwood$72K
- Todd DudleyGreenwood$63K
- Girish KunapareddyTerre Haute$329K
- Raj VuppalanchiIndianapolis$279K
- Joseph Arulandula Porte$251K
- Napoleon MamintaIndianapolis$116K
- Jennifer PaisleyLawrenceburg$112K
- Allon FriedmanIndianapolis$111K
- John AyresIndianapolis$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.